Morgante CV, Rodrigues RA, Marbach PA, Borgonovi CM, Moura DS, Silva-Filho MC
Despite advances in chemotherapy, radiotherapy, and targeted therapies, challenges such as poor drug accumulation, systemic toxicity, and multidrug resistance persist, partly due to elevated intracellular GSH levels that neutralize reactive therapeutics and reduce treatment response
A: It can reflect increased training capacity, glycogen/water shifts, appetite changes, or lean mass gain rather than pure fat gain
This spiral of damage will continue unless the free radical is neutralised
Properly reconstituted IGF-1 LR3 dissolves completely within 2 minutes without agitation when water is added slowly down the vial wall rather than directly onto the lyophilised powder